Pathogenesis of Borrelia burgdorferi induced arthritis
伯氏疏螺旋体诱发关节炎的发病机制
基本信息
- 批准号:7033003
- 负责人:
- 金额:$ 33.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:BorreliaLyme diseasearthritisautoimmunitybiological signal transductioncartilage disordercell membraneclinical researchcollagenasecytokineenzyme induction /repressionenzyme linked immunosorbent assayhuman tissueinfectious arthritislaboratory mousemedical complicationmicroarray technologypathologic processpolymerase chain reactionsecondary infectionsynovial fluidtissue /cell culturetoll like receptor
项目摘要
DESCRIPTION (provided by the applicant): Arthritis is a late manifestation of
Lyme disease. Allowed to progress untreated, Lyme arthritis can result in a
severe, erosive arthritis. The majority of patients improve with antibiotic
therapy, but a small percentage will continue to have persistent arthritis.
Whether the cause of this post-treatment arthritis is due to persistence of the
organism or autoimmune disease is an area of intense debate. The mechanisms by
which B. burgdorferi can cause cartilage degradation have not been well
studied. Unlike other bacteria that cause septic arthritis, B. burgdorferi does
not secrete any enzymes capable of digesting extracellular matrix proteins in
the joint. Matrix metalloproteinases (MMPs) are host enzymes that are capable
of digesting multiple components of human cartilage. We have found evidence
that MMPs are elevated in the synovial fluid of patients with Lyme arthritis.
The pattern of MMP induction in patients with untreated and persistent disease
is significantly different, suggesting that they may occur through different
mechanisms. We have found that B. burgdorferi stimulates MMP induction from
chondrocytes in a pattern similar to that found in patients with untreated Lyme
arthritis, but dissimilar to that seen in patients after antibiotic therapy.
The presence of B. burgdorferi results in degradation of cartilage explants in
vitro. MMP inhibitors can block this degradation. Our main hypothesis is that
cartilage erosions in patients with Lyme arthritis occurs through the induction
of MMPs from joint tissue by contact with B. burgdorferi while arthritis in
patients post-antibiotic therapy is due to activation of different MMPs through
different pathways (e.g. autoimmune).
In this proposal, we will take advantage of a large sample bank of patients
with untreated and post-treatment Lyme arthritis to fully characterize MMP and
cytokine expression in the joints. A full understanding of the MMP profiles in
these patients will allow us to make comparisons between patients with
untreated and post-treatment Lyme arthritis as well as to patients with other
arthritides and attempt to correlate specific MMPs with disease manifestations.
We will also correlate our findings with studies of MMPs in the mouse joint.
Using the mouse model of Lyme arthritis, we will study the role of specific
cell types in MMP production in the joint. Then, having identified MMPs
potentially relevant in Lyme arthritis, we will examine the effects of specific
MMP inhibitors or genetic knockouts of MMP genes on the course of murine
arthritis. Finally, we will determine signaling pathways activated by B.
burgdorferi that result in induction of pathogenic MMPs. Recent investigations
have identified a group of receptors, designated Toll-like receptors (TLRs), as
important pattern recognition receptors for bacterial products. Using TLR
blocking antibodies, dominant negative cell lines and knockout mice, we will
dissect the signaling pathways that lead to MMP induction.
We believe that studies of MMPs in Lyme disease will lead to a better
understanding of the pathogenesis of untreated and persistent Lyme arthritis.
In addition, the presence of a clear initiator and excellent animal models of
disease allow us to define the role of MMPs in Lyme arthritis in a manner not
possible for other arthritides such as rheumatoid arthritis and may
subsequently lead to the development of more specific therapies.
描述(由申请人提供):关节炎是一种晚期表现
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of adrenomedullin in Lyme disease
肾上腺髓质素在莱姆病中的作用
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:3.1
- 作者:Marre ML;Darcy CT;Yinh J;Akira S;Uematsu S;Steere AC;Hu LT
- 通讯作者:Hu LT
Downstream signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are dependent on PI3K.
- DOI:10.4049/jimmunol.0900724
- 发表时间:2009-07-01
- 期刊:
- 影响因子:0
- 作者:Shin OS;Miller LS;Modlin RL;Akira S;Uematsu S;Hu LT
- 通讯作者:Hu LT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linden T Hu其他文献
Case 24-2015
案例24-2015
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Linden T Hu;Athe M. N. Tsibris;John A. Branda - 通讯作者:
John A. Branda
Linden T Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linden T Hu', 18)}}的其他基金
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome
自身抗体作为治疗后莱姆病综合征的预测标记
- 批准号:
10737996 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
Laboratory for Combinatorial Drug Regimen Design for Resistant and Emerging Pathogens
耐药和新发病原体组合药物方案设计实验室
- 批准号:
10596722 - 财政年份:2022
- 资助金额:
$ 33.55万 - 项目类别:
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi
人类先天免疫突变在伯氏疏螺旋体耐受性丧失中的作用
- 批准号:
10461854 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi
新型水库靶向伯氏疏螺旋体抗生素的开发和现场测试
- 批准号:
10397615 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi
人类先天免疫突变在伯氏疏螺旋体耐受性丧失中的作用
- 批准号:
10680556 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi
新型水库靶向伯氏疏螺旋体抗生素的开发和现场测试
- 批准号:
10606624 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi
新型水库靶向伯氏疏螺旋体抗生素的开发和现场测试
- 批准号:
10165497 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi
人类先天免疫突变在伯氏疏螺旋体耐受性丧失中的作用
- 批准号:
10256713 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi
新型水库靶向伯氏疏螺旋体抗生素的开发和现场测试
- 批准号:
10674121 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Understanding Human Immunological Responses to Ixodes Tick Bites
了解人类对硬蜱叮咬的免疫反应
- 批准号:
9807836 - 财政年份:2019
- 资助金额:
$ 33.55万 - 项目类别:
相似海外基金
Identification of linear plasmid lp36-encoded virulence determinants in the Lyme disease spirochete Borrelia burgdorferi
莱姆病螺旋体伯氏疏螺旋体中线性质粒 lp36 编码的毒力决定簇的鉴定
- 批准号:
10372391 - 财政年份:2021
- 资助金额:
$ 33.55万 - 项目类别:
Identification of linear plasmid lp36-encoded virulence determinants in the Lyme disease spirochete Borrelia burgdorferi
莱姆病螺旋体伯氏疏螺旋体中线性质粒 lp36 编码的毒力决定簇的鉴定
- 批准号:
10514623 - 财政年份:2021
- 资助金额:
$ 33.55万 - 项目类别:
Development of an automated IVD for the ultra-sensitive, direct, molecular detection of Borrelia for early Lyme Disease
开发自动化 IVD,用于对早期莱姆病的疏螺旋体进行超灵敏、直接的分子检测
- 批准号:
10404611 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Development of an automated IVD for the ultra-sensitive, direct, molecular detection of Borrelia for early Lyme Disease
开发自动化 IVD,用于对早期莱姆病的疏螺旋体进行超灵敏、直接的分子检测
- 批准号:
10077755 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Development of an automated IVD for the ultra-sensitive, direct, molecular detection of Borrelia for early Lyme Disease
开发自动化 IVD,用于对早期莱姆病的疏螺旋体进行超灵敏、直接的分子检测
- 批准号:
10192650 - 财政年份:2020
- 资助金额:
$ 33.55万 - 项目类别:
Borrelia antigen detection assay for urine-based diagnosis of early Lyme disease
疏螺旋体抗原检测用于尿液诊断早期莱姆病
- 批准号:
9056639 - 财政年份:2015
- 资助金额:
$ 33.55万 - 项目类别:
Borrelia antigen detection assay for urine-based diagnosis of early Lyme disease
疏螺旋体抗原检测用于尿液诊断早期莱姆病
- 批准号:
8948914 - 财政年份:2015
- 资助金额:
$ 33.55万 - 项目类别:
Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease
伯氏疏螺旋体诱导的莱姆病自身免疫
- 批准号:
9757687 - 财政年份:2013
- 资助金额:
$ 33.55万 - 项目类别:
Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease
伯氏疏螺旋体诱导的莱姆病自身免疫
- 批准号:
10215511 - 财政年份:2013
- 资助金额:
$ 33.55万 - 项目类别:
Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease
伯氏疏螺旋体诱导的莱姆病自身免疫
- 批准号:
9980768 - 财政年份:2013
- 资助金额:
$ 33.55万 - 项目类别: